Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Cynata Therapeutics – Producing Stem Cells for Regenerative Medicine ...
Cynata Therapeutics
Cynata Therapeutics to talk stem cell therapies at Proactive’s CEO ...
Cynata recruits first respiratory patient for stem cells clinical trial ...
Cynata Files New Patent Application for Cymerus™ Technology in Oncology
Cynata Therapeutics opens first US site in Phase 2 CYP-001 trial - YouTube
#stemcelltherapy #medicaladvancements | Cynata Therapeutics
How Cynata Therapeutics is accelerating iPSC therapeutics ...
Cynata Therapeutics (ASX:CYP) is advancing Cymerus™️, a proprietary ...
Cynata Approved to Launch World’s 1st Clinical Trial with an Allogeneic ...
Cynata Therapeutics jumps as FDA OK’s stem cell rejection treatment
Cynata stem cells test positive for heart attack repair | The West ...
Cynata is changing the future of medical treatment through a ...
Cynata Therapeutics Ltd to talk stem cell therapies at Proactive’s CEO ...
Cynata stem cell technology a triumph: scientist | Stockhead
Cynata achieves world-first stem cell manufacturing breakthrough
Cynata Therapeutics advances Stem Cell Therapy for rare disease with ...
Cynata Therapeutics Ltd wins U.S. patent for stem cell technology
Cynata CYP-001 Stem Cell Therapy Meets All Safety and
Cynata Therapeutics gets $1 M grant to develop heart disease treatment
Cynata teams up with Leiden University Medical Center to test its stem ...
Why invest in stem cell therapies? 🧬💉 Cynata is a clinical stage ...
Cynata includes coronary artery disease into existing stem cell therapy ...
Cynata to expand recruitment criteria in Covid-19 treatment trial
Cynata raises $15 million to fast-track stem cell therapies | The West ...
Cynata recruits first patient for Phase 2 trial of stem cells for graft ...
Cynata seals partnership for US stem cell therapy push | The West ...
Sistemic and Cynata Announce Cooperation on In-process Purity Assay ...
Cynata looking to revolutionise stem cell therapy | The West Australian
Cynata adding target indications : r/CynataTherapeutics
ASX:CYP - Cynata Presenting at Advanced Therapies Congress
Cynata Therapeutics on LinkedIn: #stemcells #celltherapy #clinicaltrial
Aussie Stem Cell Company Cynata Therapeutics Signs LOI with apceth GmbH
#diabetes #clinicaltrial #stemcells | Cynata Therapeutics
Biotechnology News - Cynata enters into new manufacturing partnership ...
Cynata Shares Jump as Japan's FUJIFILM Negotiates Deal to Commercialize ...
Cynata to Launch First Phase 3 Trial with iPSC-Derived Cell Therapeutic
Dr. Kilian Kelly, Ph.D. — CEO, Cynata Therapeutics — iPSC-Derived ...
Cynata launches diabetic foot ulcer clinical trial | The West Australian
Cynata Stem Cell Technology - YouTube
Cynata Therapeutics (ASX:CYP) | Webinar with Dr Kilian Kelly | 27/06/24 ...
ASX Announcements | Cynata Therapeutics
Cynata Therapeutics' Pivotal Year Ahead with Osteoarthritis and aGvHD ...
Cynata Therapeutics enrols first cohort for world first clinical trial
Cynata Therapeutics on LinkedIn: Did you know that mesenchymal stem ...
Cynata Therapeutics on LinkedIn: #celltherapy #biotech #stemcells # ...
Cynata completes enrolment in Phase II trial | The Australian
Cynata Therapeutics' breakthrough in regenerative medicine - Sequoia Direct
Cynata is excited to announce the addition of three new clinical sites ...
Cynata Therapeutics opens first US site in Phase 2 CYP-001 trial | ASX:CYP
Cynata Therapeutics (ASX: CYP) gears up for clinical progress after ...
Cynata Therapeutics Initiates Patient Treatment in World 1st Clinical ...
Cynata Therapeutics on LinkedIn: #cynatastemcells #clinical #research # ...
Cynata Therapeutic’s Cymerus™ iPSC-MSC Manufacturing Platform : r ...
Cynata Therapeutics Lands Japanese Giant Fujifilm
Cynata Therapeutics (ASX:CYP) 1H20 results & outlook | Finance News Network
Cynata Therapeutics: A $100m deal with big Pharma – now that’s remarkable!
Cynata Therapeutics elaborates on its strong pipeline of clinical ...
Cynata Therapeutics' (ASX:CYP) clinical trials gaining pace | Kalkine ...
What's ahead for stem cell play Cynata after that huge run | Stockhead
Cynata Therapeutics | Cynata Therapeutics
Cynata Therapeutics to Test Proprietary MSC Manufacturing Process in ...
Cynata approval for 1st ever allo trial of IPSC-derived MSCs for GVHD ...
Cynata Therapeutics - YouTube
Pitt Street Research Report On Cynata Therapeutics, Valuation Range A$2 ...
Cynata - Crunchbase Company Profile & Funding
Cynata Therapeutics Secures $6M in Capital Raise, $10M with Payment ...
Cynata Reports Positive 28-day Data From Cohort B of Phase
Cynata Therapeutics, Behind the Scenes with CEO Dr. Ross Macdonald
Cynata Therapeutics - Cell & Gene Meeting on the Mesa
Cynata Therapeutics Limited - Regenerative medicine (RM) is the future ...
Cynata’s Stem Cell Therapy Meets All Safety & Efficacy Endpoints in Trial
FujiFilm - Cynata's First Licensee Of Its Lead Product CYP-001 In GvHD ...
#cynata #clinicaltrial #medicalresearch #fundraising #stemcells #msc ...
Great work from Louise Smith and her team from TekCyte Limited using ...
TechInvest
Scalable MSC platform enabling next wave of stem cell therapies with Dr ...
Cynata’s iPSC-derived Cell Therapeutic (CYP-001) Meets Safety ...
#StemCells have the potential to treat a wide range of illnesses ...
Patient Treatment Commences in Cynata’s World First Clinical Trial (CYP ...
ASX Health Stocks: Big tick for Cynata's stem-cell therapy | Stockhead
We're honoured to be featured in a recent report discussing the global ...
SPECIAL FEATURE - Platform Technologies - Derisking & Transforming Drug ...
Fuji’s expected licensing will be significant validation of Cynata’s ...
Want to stay informed about Cynata's innovative approach to ...
Cynata's Collaboration With Rasko Lab - More Than "Just" CYP-001 in SR ...
FUJIFILM Cellular Dynamics would like to congratulate our partners at ...
#isct2025 #celltherapy #regenerativemedicine #ipscs #stemcells #biotech ...
#advancedtherapiescongress #regenerativemedicine #stemcells #biotech # ...
Clinical trials are an integral part of developing new therapeutic ...
CynataのCymerus™プラットフォームテクノロジー - それは何か？ | BioInformant
Acute graft versus host disease (aGvHD) can occur after a blood stem ...
We're thrilled to be named as one to watch by Bioshares among ...
Biocurious: Without a hint of hyperbole, ASX stem-cell developers lead ...
Cynata’s CYP-001 shows positive safety profile | The Australian
Revolutionizing Heart Disease Treatment with iPSC-Derived MSCs ...
Patient Enrolment Complete in Phase 2 aGvHD Clinical Trial | BioInformant
Cynata’s MSC Technology Demonstrates Significant Efficacy in ...
Home | SMART CRC
Anti-biofilm & Infection Reduction Surface Coating Technologies
US FDA Clears IND for Cynata’s Phase 2 Clinical Trial of CYP-001 in ...
Research Notes | Spark Plus | Corporate Advisory Services Singapore
